Healthy Volunteer Study Using 3 Different Formulations of Firategrast

NCT01416363 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: Firategrast immediate release tablet
DRUG: Firategrast modified release tablet
DRUG: Firategrast gastro-retentive solution

Sponsor

GlaxoSmithKline